Open Access and Peer-reviewed Medical Journal
Home Journal Issues Guide for Authors Editorial Board Aims & Scope About Journal


Review Article Open Access


St Johnís Wort in the treatment against Major Depression Disorder

Sajad Ahmad Bhat, Ab Latif Wani, Anjum Ara.

Abstract
Depression is a complex mood disorder with many types and treated in a number of ways. There are large numbers of synthetic drugs which are used in treating major depressive disorder. However they are also found to have bad impact on the health of a patient. Depression is multifactorial phenomenon, in which hormonal and neurotransmitter imbalance plays imperative role in its causation. Though large number of pharmaceutical drugs is available but they also pose serious threat due to extended use as serious side effects also develop. It is very important to look for antidepressants from natural sources which are advantageous, less hazardous and has least side effects on human health. This article aims to focus on specific natural antidepressant St Johnís Wort and how it can act as alternative medicine exhibiting the potential for the treatment of depression.

Key words: Depression, Natural Antidepressants, St John Worts


 
ARTICLE TOOLS
Abstract
PDF Fulltext
Print this article Print this Article
How to cite this articleHow to cite this article
Export to
Export to
Related Records
 Articles by Sajad Ahmad Bhat
Articles by Ab Latif Wani
Articles by Anjum Ara
on Google
on Google Scholar
Article Statistics
 Viewed: 1191
Downloaded: 408
Cited: 0


REFERENCES
1.Kruijshaar ME, Barendregt J, Vos T, et al. Life time prevalence estimates of major depression: an indirect estimation method and quantification of recall bias. Eur J Epidemiol. 2005; 20:103-111. [DOI via Crossref]    [Pubmed]   
2.Smith AJ, Sketris I, Cooke C, et al. A comparison of antidepressant use in Nova Scotia, Canada and Australia. Pharmacoepidemiol Drug Saf. 2008; 17:697-706. [DOI via Crossref]    [Pubmed]   
3.Tierney LM, McPhee SJ, Papadakis MA, eds. Current Medical Diagnosis & Treatment. 45th ed. SanFrancisco, CA: McGrawHill; 2006:1065-1066.
4.Mann JJ. The medical management of depression. N Engl J Med. 2005; 353:1819-1834. [DOI via Crossref]    [Pubmed]   
5.Bhat SA, Wani AL, Ara A, Saidullah B. An epidemiological study on depression and its comorbidity. Int J of Latest Res Science and Tech. 2014; 3(4): 12-17.
6.Wani AL, Ara A, Bhat SA. "Blood Injury and Injection Phobia: The Neglected One," Behav Neurol 2014; vol. Article ID 471340, 7 pages, 2014. [DOI via Crossref]    [DOI via Crossref]   
7. Hansson L. Quality of life in depression and anxiety. Int Rev Psychiatry 2002; 14:185-189. [DOI via Crossref]   
8.Andrews G, Titov N. Depression is very disabling. Lancet. 2007;370:808-809. [DOI via Crossref]   
9.Tomas K, Coleman P. Use of complementary or alternative medicine in a general population in Great Britain. Results from the National Omnibus survey. J Public Health. 2004;26:152-157. [DOI via Crossref]    [Pubmed]   
10. Zhou SF, Lai X. An update of clinical drug interactions with the herbal antidepressant St. John's wort. Curr Drug Metab. 2008; 9:394-409. [DOI via Crossref]    [Pubmed]   
11. Tindle HA, Davis RB, Phillips RS, Eisenberg DM.Trends in the use of complementary and alternative medicine by US adults: 1997-2002. Altern ther Health Med. 2005; 11:42-49. [Pubmed]   
12. Mehta, Sweety (2012-12-18). Pharmacognosy of St john's Wort. Pharmaxchange.info. Retrieved 2014-02-16.
13. Nathan, PJ. "Hypericum perforatum (St John's Wort): a nonselective reuptake inhibitor? A review of the recent advances in its pharmacology". Journal of psychopharmacology (Oxford, England). 2001;15(1):47‚Äď54. [DOI via Crossref]   
14. Ernst E 1999 Second thoughts about safety of St John's wort. Lancet 354; 2014-2016. [DOI via Crossref]   
15. Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W & Melchart D. St John's wort for depression - an overview and meta-analysis of randomised clinical trials. Br Med J. 1996; 313 253-258. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
16. Hemeryck A, Belpaire FM. Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug‚Äďdrug interactions: an update. Curr Drug Metabl. 2002; 3:13‚Äď37. [DOI via Crossref]   
17. Mueller SC, Uehleke B,Woehling H, et al. Effect of St John's wort dose and preparations on the pharmacokinetics of digoxin. Clin Pharmacol Ther. 2004;75:546‚Äď557. [DOI via Crossref]    [Pubmed]   
18. Izzo AA. Drug interactions with St. John's wort (Hypericum perforatum): a review of the clinical evidence. Int J Clin Pharmacol Ther.2004; 42: 139‚Äď148. [DOI via Crossref]   
19. Muller WE, Singer A, Wonnermann M, Hafner U, Rolli M and Schafer C, Hyperforin represents the neurotransmitter reuptake inhibiting constituent of Hypericum extract, Pharmacopsychiatry. 1998; Suppl (1) 16-21
20. Chatterjee SS, Bhattacharya SK, Wonnermann M, Singer A and Muller WE, Hyperforin as a possible antidepressant component of Hypericum extract, Life Sci. 1998; 63: 499-510. [DOI via Crossref]   
21. Barnes J, Anderson LA and Phillipson JD, St. John's wort (H. perforatum L): a review of its chemistry, pharmacology and clinical properties, J Pharm Pharmacol. 2001:53: 583-600. [DOI via Crossref]    [Pubmed]   
22. Singer A, Wonnermann M and Muller WE, Hyperforin, a major antidepressant constituent of St. John's wort, inhibits serotonin uptake by elevating free intracellular Na+, J Pharmacol Exp Ther. 1999: 290: 1363-1368. [Pubmed]   
23. Calapai G, Crupi A, Firenzuoli F, Inferrera G, Squadrito F, Parisi A, De Sarro G and CaputiA, Serotonin, norepinephrine and dopamine involvement in the antidepressant action of Hypericum perforatum. Pharmacopsychiatry, 2001; 34(2): 45-49. [DOI via Crossref]    [Pubmed]   
24. Yu PH, Effect of the Hypericum perforatum on serotonin turnover in the mouse brain, Pharmacopsychiatry. 2000; 33(2): 60-65. [DOI via Crossref]    [Pubmed]   
25. Muller WE, Rolli M, Schafer C and Hafner U, Effects of Hypericum extract in biochemical models of antidepressant activity, Pharmacopsychiatry. 1997; 30(2):102-107. [DOI via Crossref]    [Pubmed]   
26. Muller WE, Singer A and Wonnemann M, Mechanism of action of St. John's wort extract, Schweiz Rundsch Med Prax. 2000; 89(50): 2111-2121.
27. Sarris J. St. John's Wort for the treatment of psychiatric disorders. Psychiatr Clin North Am. 2013; 36(1):65-72. [DOI via Crossref]    [Pubmed]   
28. Pirotta M, Willis K, Carter M, Forsdike K, Newton D, Gunn J. 'Less like a drug than a drug': The use of St John's Wort among people who self-identify as having depressionand/or anxiety symptoms. Complement Ther Med. 2014; 22(5):870-6. [DOI via Crossref]    [Pubmed]   
29. Sell TS, Belkacemi T, Flockerzi V, Beck A. Protonophore properties of hyperforin are essential for its pharmacological activity. Sci Rep. 2014;4:7500. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
30. Tian J, Zhang F, Cheng J, Guo S, Liu P, Wang H. Antidepressant-like activity of adhyperforin, a novel constituent of Hypericum perforatum L. Sci Rep. 2014; 4:5632. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
31. Vance KM, Ribnicky DM, Hermann GE, Rogers RC. St. John's Wort enhances the synaptic activity of the nucleus of the solitary tract. Nutrition. 2014; 30(7-8 Suppl): S37-42.
32. Bukhari IA, Dar A.Behavioral profile of ypericum perforatum (St. John's Wort) extract. A comparison with standard anti depressants in animal models of depression. Eur Rev Med Pharmacol Sci. 2013; 17(8):1082-1089. [Pubmed]   
33. Linde K, Berner MM, Kriston L. St John's wort for major depression. Cochrane Database Syst Rev. 2008 Oct 8;(4):CD000448. [DOI via Crossref]   
34. Bouron A, Lorrain E. Cellular and molecular effects of the antidepressant hyperforin on brain cells: Review of the literature. Encephale. 2014; 40(2):108-13. [DOI via Crossref]    [Pubmed]   
35. Husain GM, Chatterjee SS, Singh PN, Kumar V. Beneficial effect of Hypericum perforatum on depression and anxiety in a type 2 diabetic rat model. Acta Pol Pharm. 2011;68(6):913-8. [Pubmed]   
36. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005; 352 (11): 1112‚Äď20. [DOI via Crossref]    [Pubmed]   
37. Gillman PK. A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action. Biol Psychiatry.2011; 59 (11): 1046‚Äď51. [DOI via Crossref]    [Pubmed]   
38. Isbister GK, Buckley NA, Whyte IM."Serotonin toxicity: a practical approach to diagnosis and treatment". Med J Aust. 2007; 187 (6): 361-5. [Pubmed]   
39. Strawn JR, Keck PE, Caroff SN. "Neuroleptic malignant syndrome". Am J Psychiatry. 2007; 164 (6): 870‚Äď6. [DOI via Crossref]    [Pubmed]   

How to Cite this Article
Pubmed Style

Bhat SA, Wani AL, Ara A. St Johnís Wort in the treatment against Major Depression Disorder. Ulutas Med J. 2015; 1(2): 16-21. doi:10.5455/umj.20150418040725



Web Style

Bhat SA, Wani AL, Ara A. St Johnís Wort in the treatment against Major Depression Disorder. www.scopemed.org/?mno=182816 [Access: November 24, 2017]. doi:10.5455/umj.20150418040725



AMA (American Medical Association) Style

Bhat SA, Wani AL, Ara A. St Johnís Wort in the treatment against Major Depression Disorder. Ulutas Med J. 2015; 1(2): 16-21. doi:10.5455/umj.20150418040725



Vancouver/ICMJE Style

Bhat SA, Wani AL, Ara A. St Johnís Wort in the treatment against Major Depression Disorder. Ulutas Med J. (2015), [cited November 24, 2017]; 1(2): 16-21. doi:10.5455/umj.20150418040725



Harvard Style

Bhat, S. A., Wani, A. L. & Ara, A. (2015) St Johnís Wort in the treatment against Major Depression Disorder. Ulutas Med J, 1 (2), 16-21. doi:10.5455/umj.20150418040725



Turabian Style

Bhat, Sajad Ahmad, Ab Latif Wani, and Anjum Ara. 2015. St Johnís Wort in the treatment against Major Depression Disorder. THE ULUTAS MEDICAL JOURNAL, 1 (2), 16-21. doi:10.5455/umj.20150418040725



Chicago Style

Bhat, Sajad Ahmad, Ab Latif Wani, and Anjum Ara. "St Johnís Wort in the treatment against Major Depression Disorder." THE ULUTAS MEDICAL JOURNAL 1 (2015), 16-21. doi:10.5455/umj.20150418040725



MLA (The Modern Language Association) Style

Bhat, Sajad Ahmad, Ab Latif Wani, and Anjum Ara. "St Johnís Wort in the treatment against Major Depression Disorder." THE ULUTAS MEDICAL JOURNAL 1.2 (2015), 16-21. Print. doi:10.5455/umj.20150418040725



APA (American Psychological Association) Style

Bhat, S. A., Wani, A. L. & Ara, A. (2015) St Johnís Wort in the treatment against Major Depression Disorder. THE ULUTAS MEDICAL JOURNAL, 1 (2), 16-21. doi:10.5455/umj.20150418040725








AUTHOR LOGIN

REVIEWER LOGIN

Indexed
&
Abstracted


CrossRef

ScopeMed

Google Scholar

TUBITAK Dergipark

Index Scholar

Index Copernicus


ABOUT JOURNAL
POLICIES and STATEMENTS

The articles in Ulutas Medical Journal are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.